Biomarkers for Immune Checkpoint Inhibitors: The Importance of Tumor Topography and the Challenges to Cytopathology

Cancer cytopathology - United States
doi 10.1002/cncy.21951
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Current Landscape and Future Directions of Biomarkers for Predicting Responses to Immune Checkpoint Inhibitors

Cancer Management and Research
Oncology
2018English

Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2019English

Immune Checkpoint Therapy and the Search for Predictive Biomarkers

Cancer Journal
Cancer ResearchOncology
2016English

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Promises and Challenges

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

Frontiers in Immunology
AllergyImmunology
2020English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and the ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

Cancers
Cancer ResearchOncology
2019English

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors

Frontiers in Oncology
Cancer ResearchOncology
2019English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy